Abstract
It is well known that patients with atrial fibrillation (AF) have a 5-fold increased risk of stroke compared to those without AF [1]. Moreover, the incidence of ischemic stroke in asymptomatic or recurrent paroxysmal AF is comparable to this one in chronic AF. In this setting, the knowledge of the physicians about the anticoagulation therapy in AF is essential to reduce the AF complications and to improve the quality of patients' life.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
